Overcome the limitations associated with current approaches for comprehensive genomic profiling (CGP) with the QIAseq Pan-cancer Multimodal Panel to reliably detect DNA and RNA biomarkers using a consolidated workflow from total nucleic acids.
The panel is the only one-day, low-input sample to sequencing workflow for simultaneous and comprehensive genomic profiling of DNA variants, RNA fusions and assessing TMB/MSI in solid tumors and heme malignancies. This solution has a lower sample input requirement that is ≥50% less than conventional approaches for increased compatibility with samples of limited availability.
More information
